Lipopolysaccharide (10 pg/ml) was found to stimulate resident mouse peritoneal macrophages to produce leukotriene C4 (36 k 1.3 ng/106 cells, SEM, n = 20) within 16 h. Spontaneous synthesis in control cultures without lipopolysaccharide was < 1.6 ng/106 cells. Leukotriene C4 was characterized by reversed-phase highperformance liquid chromatography, ultraviolet spectrometry and radioimmunoassay. When the macrophages, prelabeled with [3H]arachidonic acid, were treated with lipopolysaccharide radioactivity was incorporated into leukotriene C,. The amount produced varied with the method of macrophage preparation and incubation conditions and was dependent on the amount of lipopolysaccharide added (0.5 -60 pg/ml), on cell counts and on the incubation time (4-16 h). The released leukotriene C, was converted to a compound identified as a C6-cysteinylleukotriene, indicating metabolism of the leukotriene by the macrophages. Parallel determinations of prostaglandins Ez and Fza by radioimmunoassay demonstrated that leukotriene C, and prostaglandin E2 are formed by mouse peritoneal macrophages to a similar degree.Lipopolysaccharides (endotoxins) represent characteristic surface components of gram-negative bacteria. They are believed to contribute to the pathogenesis and manifestations of gram-negative infection (for review see [l, 21). The mechanisms underlying the toxic events of lipopolysaccharide in vivo, however, are not clearly understood.It has previously been demonstrated that treatment of mouse peritoneal macrophages [3 -51, alveolar macrophages [6] and rat Kupffer cells [7] with lipopolysaccharide resulted in the release of several cyclooxygenase products. These metabolites of arachidonic acid are believed to mediate some of the biological effects induced by lipopolysaccharide [8,9] released leukotrienes were not dependent on the lipopolysaccharide concentration, this cell type may nevertheless represent a cellular source of leukotrienes in septic shock. In the present study the question was addressed as to whether macrophages, which are well known target cells of lipopolysaccharide, are capable of producing lipoxygenase products in response to lipopolysaccharide treatment. It will be shown that under specified conditions, lipopolysaccharide activates mouse peritoneal macrophages (MPM) to secrete LTC, and that these cells exhibit the capacity to metabolize released LTC,. Some of the present data have been presented in a preliminary form [21,22].
MATERIALS AND METHODS
MaterialsIscove's modified Dulbecco's medium (Iscove's medium) was purchased from Gibco Limited (Paisley, Scotland). Prostaglandins Ez, Fza and L-glutathione (reduced) were obtained from Serva (Heidelberg, FRG). Synthetic LTC, was kindly donated by Dr J. Rokach (Merk Frosst, Canada). 5,6,8,9,11,12,14,15-[3H]Arachidonic acid (specific activity 62.2 Ci/mmol), tritium-labeled leukotrienes (LTC,, LTD,, LTE,, LTB,), prostaglandins (PGEz, PGFza) and a LTC4 RIA kit were purchased from New England Nuclear (Dreieich, FRG). L-(+)-Ascorbic acid was from Merck (Dar...